Scienture Holdings, Inc. (SCNX)
Nasdaq: SCNX · Pharmaceutical Preparations · Commack, NY · filing with the SEC since 2007
Who owns Scienture Holdings, Inc.
As filed with the SECHolders of 5% or more
0
No Schedule 13D or 13G naming this company is on file.
Directors and officers
3
report now, of 14 people on the record since 2014. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 0 named at left.
Holders of 5% or moreshare of the class, as filed
Scoggin International Fund Ltd.
SCHEDULE 13G · filed Aug 20, 2025 · Common Stock, par value $0.00001 per share · reported falling below 5%
L1 Capital Global Opportunities Master Fund, Ltd.
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.00001 per share · reported falling below 5%, from 5.55% in Aug 19, 2025
What SCNX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
ARBLI Losartan Oral Potassium Suspension
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Hudson Global Ventures LLC
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Integral Health
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
IPS Lease
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
IPS, Softell and Bonum
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Superlatus, Inc.
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Trxade, Inc.
An entity · legal entity · owns, named in the 10-K filed Mar 30, 2026
Scienture Inc
A company bought · acquisition, legal entity, related party · Jul 2024 · owns, named in the 10-K filed Mar 30, 2026
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 30, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2022 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.